Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ying‑Ke Liang"'
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0615-x.
Externí odkaz:
https://doaj.org/article/d042f4c5d6534ece87fd5ad57750dda9
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Even though aberrant expression of microRNA (miR)-30d has been reported in prostate cancer (PCa), its associations with cancer progression remain contradictory. The aim of this study was to investigate clinical significance, biolo
Externí odkaz:
https://doaj.org/article/dafef72eefd84824ae9aabaaf94a8720
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-2 (2019)
After publication of the article [1], the author reported that this article contained some errors.
Externí odkaz:
https://doaj.org/article/d0690d58a7594798b70a58449981c3ce
Autor:
Qing-biao Chen, Ying-ke Liang, Yan-qiong Zhang, Min-yao Jiang, Zhao-dong Han, Yu-xiang Liang, Yue-ping Wan, Jie Yin, Hui-Chan He, Wei-de Zhong
Publikováno v:
Tumor Biology, Vol 39 (2017)
As a member of helix–loop–helix protein family, transcription factor 12 functions as either an oncogene or a tumor suppressor in various human cancers. However, there are no reports on its involvement in prostate cancer. To investigate clinical r
Externí odkaz:
https://doaj.org/article/3338c7bd8b9349b8a09aef6c8d6406fb
Autor:
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Publikováno v:
Disease Markers.
Background. In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV) gene was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4acdc73f98cf3040e277463149a011
Autor:
Yu-Xiang, Liang, Ying-Ke, Liang, Zhi-Hao, Zou, Yang-Jia, Zhuo, Jian-Heng, Ye, Xue-Jin, Zhu, Zhou-Da, Cai, Zhuo-Yuan, Lin, Ru-Jun, Mo, Shu-Lin, Wu, Yan-Qiong, Zhang, Wei-De, Zhong
Publikováno v:
Disease markers. 2022
In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV mRNA expression was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::455d2a22be44cba7de01f479cd4e01ed
https://pubmed.ncbi.nlm.nih.gov/35548776
https://pubmed.ncbi.nlm.nih.gov/35548776
Autor:
Ru-Jun, Mo, Zhao-Dong, Han, Ying-Ke, Liang, Jian-Heng, Ye, Shu-Lin, Wu, Sharron X, Lin, Yan-Qiong, Zhang, Sheng-Da, Song, Fu-Neng, Jiang, Wei-De, Zhong, Chin-Lee, Wu
Publikováno v:
International journal of cancer. 144(12)
To investigate immune profile consisting of stromal PD-L1 expression, inhibitory or non-T-cell inflamed tumor microenvironment that may predict response to anti-PD-L1/PD-1 immunotherapy in prostate cancer, we validated the specificity of a PD-L1 mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::489615005478907a654f0a4ac18ffb8b
https://pubmed.ncbi.nlm.nih.gov/30537104
https://pubmed.ncbi.nlm.nih.gov/30537104
Autor:
Ruidong Li, Wei-de Zhong, Renyuan Ma, Weimin Dong, Zhenyu Jia, Ying-Ke Liang, Han Qu, Le Zhang, Hui-chan He, Zhao-Dong Han, Shibo Wang, Ru-Jun Mo, Yangjia Zhuo, Jianming Lu, Jianguo Zhu
Publikováno v:
International journal of biological macromolecules. 118
Although dCTP pyrophosphatase 1 (DCTPP1) has been reported to be associated with poor clinical outcomes in various cancers, whether it plays an important role in prostate cancer (PCa) remains unclear. In this study, an immunohistochemical assay showe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f4db0300e789a07d0936bd4318a7d2
https://pubmed.ncbi.nlm.nih.gov/29874556
https://pubmed.ncbi.nlm.nih.gov/29874556
Autor:
Jun-Xu Chen, Hui-chan He, Yu-Xiang Liang, Ze-Zhen Liu, Zhao-Dong Han, Ying-Ke Liang, Xuejin Zhu, Weide Zhong, Jianheng Ye, Jianming Lu, Yangjia Zhuo
Publikováno v:
Journal of cellular biochemistry. 119(9)
AT-rich interaction domain 4A (ARID4A) and AT-rich interaction domain 4B (ARID4B), which are both the AT-rich interaction domain (ARID) family, have been reported to be oncogene or tumor suppressor gene in various human malignances, but there is no i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a67b49a48b84e8cd5c40123dbdc8cb4
https://pubmed.ncbi.nlm.nih.gov/29797600
https://pubmed.ncbi.nlm.nih.gov/29797600
Autor:
Ying-Ke Liang, Yanqiong Zhang, Yue-Ping Wan, Hui-chan He, Minyao Jiang, Yu-Xiang Liang, Zhao-Dong Han, Qing-Biao Chen, Wei-de Zhong, Jie Yin
Publikováno v:
Tumor Biology, Vol 39 (2017)
As a member of helix–loop–helix protein family, transcription factor 12 functions as either an oncogene or a tumor suppressor in various human cancers. However, there are no reports on its involvement in prostate cancer. To investigate clinical r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63029e835b070eac9270d038d079868
https://doaj.org/article/3338c7bd8b9349b8a09aef6c8d6406fb
https://doaj.org/article/3338c7bd8b9349b8a09aef6c8d6406fb